SARC-F Score: A Quick Bedside Tool to Screen Sarcopenia in Patients With Cirrhosis

Neeraj Singla; Pradev Inavolu; Bhashyakarla Ramesh Kumar; Ramanna Macherla; Duvvur Nageshwar Reddy

doi:10.1016/j.jceh.2023.101318

SARC-F Score: A Quick Bedside Tool to Screen Sarcopenia in Patients With Cirrhosis

J Clin Exp Hepatol. 2024 May-Jun;14(3):101318. doi: 10.1016/j.jceh.2023.101318. Epub 2023 Dec 13.

Authors

Neeraj Singla¹, Pradev Inavolu¹, Bhashyakarla Ramesh Kumar², Ramanna Macherla², Duvvur Nageshwar Reddy¹

Affiliations

¹ Asian Institute of Gastroenterology, Hyderabad, Telangana, India.
² Osmania Medical & Hospital, Hyderabad, Telangana, India.

PMID: 38261819
PMCID: PMC10792645 (available on 2025-05-01)
DOI: 10.1016/j.jceh.2023.101318

Abstract

Background: Sarcopenia is often ignored in clinical practice despite being an important prognostic marker. SARC-F is a simple bedside score to assess muscle abnormalities in cirrhosis patients. However, there is limited Indian data on the validity of this score. Hence, we aimed to assess the validity of SARC-F score in a tertiary care center.

Methods: A prospective observational study including consecutive 100 cirrhosis patients attending the gastroenterology outpatient department in Osmania Medical College and Hospital, Hyderabad, India, was conducted from Jan 2018 to Dec 2019. The primary aim was to assess the mean muscle volume loss (MVL) by computed tomography and handgrip (HG) strength for muscle strength decline (MSD) and compare the SARC-F score with standard cut-off values.

Results: We included 100 cirrhosis patients (mean age: 45 years; males: 86%; child-pugh class B/C: 42/58). Sixty-nine percent of the patients had a SARC-F score of ≥4, whereas MVL and MSD were noted in 62% and 86% patients, respectively. Mid-arm circumference, skin-fold thickness, mid-arm muscle circumference (MAMC), and HG strength were significantly lower in patients with SARC-F score ≥4 than in those with SARC-F score <4 (P < 0.05). The Pearson correlation plot suggested a significant inverse correlation between the SARC-F score and MSD and SARC-F score and MVL. A SARC-F score of ≥4 had a sensitivity and specificity of 80.7% and 50% for MVL and 75.6% and 71.4% for MSD, respectively, whereas it was 83.3% and 52.5% for MSD and MVL combined, respectively. Area under the receiver operating characteristic curve for SARC-F as a predictor of MVL was 0.75 (95% confidence interval: 0.64-0.82; P=<0.001). On multivariate analysis, a high SARC-F score and low MAMC were predictive of MVL in cirrhosis patients.

Conclusion: SARC-F score has good sensitivity as a bedside screening tool for sarcopenia in patients with cirrhosis. A high SARC-F score and low MAMC indicates the presence of MVL and warrants further evaluation for sarcopenia.

Keywords: SARC-F score; chronic liver disease; cirrhosis; mid-arm muscle circumference; sarcopenia.